• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method.

作者信息

Drugeon H B, Caillon J, Juvin M E, Pirault J L

出版信息

J Antimicrob Chemother. 1987 Feb;19(2):197-203. doi: 10.1093/jac/19.2.197.

DOI:10.1093/jac/19.2.197
PMID:3106301
Abstract

Since in-vitro methods for studying drug interactions are difficult to evaluate and different results occur with the chequerboard (isobolograms-FIC index) and killing curve methods, a new approach associating these two methods was used to study the ceftazidime-pefloxacin interaction. In 64 tubes in a chequerboard pattern, viable bacteria were counted at 0, 2.5, 5 and 24 h, by a microdilution method and a multiple inoculator replicating method. The bacterial inoculum consisted of 5 X 10(6)-10(7) cfu/ml. Twelve strains belonging to six genera were tested: Acinetobacter, Citrobacter, Enterobacter, Klebsiella, Serratia and Pseudomonas. During the first 5 h no antagonism was noted, but few differences in viable count equal to or greater than 2 log10 were observed. The results of the drug interaction were equivalent to those of the more rapid bactericidal antibiotic concentrations (ceftazidime or pefloxacin). At 24 h, synergy was observed: ceftazidime prevented the late regrowth noted with pefloxacin, but with Citrobacter spp. regrowth was also observed with ceftazidime and none of the combinations were bactericidal.

摘要

相似文献

1
Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method.
J Antimicrob Chemother. 1987 Feb;19(2):197-203. doi: 10.1093/jac/19.2.197.
2
In-vitro activity of pefloxacin compared to other antibiotics.培氟沙星与其他抗生素相比的体外活性。
J Antimicrob Chemother. 1986 Apr;17 Suppl B:19-28. doi: 10.1093/jac/17.suppl_b.19.
3
Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.
J Antimicrob Chemother. 1988 Jan;21(1):49-55. doi: 10.1093/jac/21.1.49.
4
[In vitro antibacterial activity of piperacillin/quinolone combinations].哌拉西林/喹诺酮类联合用药的体外抗菌活性
Pathol Biol (Paris). 1988 May;36(5):357-60.
5
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
J Antimicrob Chemother. 1986 Mar;17 Suppl A:11-8. doi: 10.1093/jac/17.suppl_a.11.
6
[Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Pathol Biol (Paris). 1987 May;35(5):467-72.
7
The comparative in-vitro activity of pefloxacin.培氟沙星的体外比较活性。
J Antimicrob Chemother. 1986 Apr;17 Suppl B:1-10. doi: 10.1093/jac/17.suppl_b.1.
8
Combination therapy: a way to limit emergence of resistance?
Am J Med. 1986 Jun 30;80(6B):138-42. doi: 10.1016/0002-9343(86)90491-2.
9
In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides.
J Antimicrob Chemother. 1986 Apr;17 Suppl B:11-7. doi: 10.1093/jac/17.suppl_b.11.
10
[In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter].
Pathol Biol (Paris). 1986 May;34(5):436-9.

引用本文的文献

1
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.利奈唑胺联合厄他培南的体外和体内评估:一种对耐甲氧西林金黄色葡萄球菌具有高度协同作用的联合用药。
Antimicrob Agents Chemother. 2006 Jul;50(7):2547-9. doi: 10.1128/AAC.01501-05.
2
Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients.
Intensive Care Med. 1993;19(5):285-9. doi: 10.1007/BF01690549.
3
In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.环丙沙星和培氟沙星在粘质沙雷氏菌心内膜炎实验模型中的体内杀菌活性。
Antimicrob Agents Chemother. 1994 Apr;38(4):883-5. doi: 10.1128/AAC.38.4.883.
4
Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.环丙沙星和培氟沙星单独使用或与磷霉素联合使用在多药敏感和耐药铜绿假单胞菌引起的实验性心内膜炎中的比较疗效。
Antimicrob Agents Chemother. 1995 Feb;39(2):496-9. doi: 10.1128/AAC.39.2.496.
5
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.给药方案对庆大霉素、妥布霉素或阿米卡星在粘质沙雷氏菌心内膜炎实验模型中疗效的影响:体外-体内相关性
Antimicrob Agents Chemother. 1991 Jan;35(1):111-6. doi: 10.1128/AAC.35.1.111.
6
Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.在革兰氏阴性心内膜炎实验模型中影响体内氨基糖苷类活性的因素鉴定。
Antimicrob Agents Chemother. 1992 Apr;36(4):744-50. doi: 10.1128/AAC.36.4.744.